Nexodyn Wound Care Solution Launched in the U.S.

Angelini and APR Applied Pharma Research strengthen their partnership in wound care with the launch of Nexodyn in the USA.


The new Nexodyn AOS wound care solution, cleared for sale by the FDA, is now starting to be available in the USA, promoted and commercialized by the Italian pharmaceutical company Angelini, as a result of an exclusive partnership with the Swiss company APR Applied Pharma Research, the owner and developer of the proprietary, patented technology TEHCLO, for the production of acidic super-oxidizing solutions.


Nexodyn helps cleanse and moisten the wound environment by removing dirt, debris and foreign material by flushing across the wound. Nexodyn is intended for use, under the supervision of healthcare … read more